Last reviewed · How we verify

Sodium < 1mEq/kg/day

Hospital del Niño "Dr. Federico Gomez Santos" · FDA-approved active Small molecule

Sodium restriction at <1mEq/kg/day reduces total body sodium content to manage fluid balance and electrolyte homeostasis.

Sodium restriction at <1mEq/kg/day reduces total body sodium content to manage fluid balance and electrolyte homeostasis. Used for Fluid overload management in pediatric patients, Heart failure in children, Chronic kidney disease with sodium retention.

At a glance

Generic nameSodium < 1mEq/kg/day
SponsorHospital del Niño "Dr. Federico Gomez Santos"
ModalitySmall molecule
Therapeutic areaCardiology, Nephrology, Pediatrics
PhaseFDA-approved

Mechanism of action

This is a dietary sodium restriction protocol rather than a pharmacological drug. It limits daily sodium intake to less than 1 milliequivalent per kilogram of body weight, which reduces extracellular fluid volume and helps manage conditions characterized by sodium and fluid retention. This approach is commonly used in pediatric patients with conditions such as heart failure, renal disease, or hypertension.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: